Extavia and Gastric ulcer - a phase IV clinical study of FDA data

Summary:

Gastric ulcer is reported as a side effect among people who take Extavia (interferon beta-1b), especially for people who are female, 50-59 old, also take Bisoprolol Fumarate And Hydrochlorothiazide, and have Headache.

The phase IV clinical study analyzes which people have Gastric ulcer when taking Extavia. It is created by eHealthMe based on reports of 4,879 people who have side effects when taking Extavia from the FDA, and is updated regularly.

What is Extavia?

Extavia has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 4,888 Extavia users. Check the latest studies of Extavia.

What is Gastric ulcer?

Gastric ulcer (stomach ulcer) is found to be associated with 1,954 drugs and 3,385 conditions by eHealthMe. Check the latest studies of Gastric ulcer.

On Aug, 09, 2026

4,879 people reported to have side effects when taking Extavia.
Among them, 13 people (0.27%) have Gastric ulcer.

Among these 13 people:

What is the gender of people who have Gastric ulcer when taking Extavia? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Gastric ulcer when taking Extavia? *

What are other drugs people take besides Extavia? *

Captopril: 4 people, 30.77%
Pantoprazole: 4 people, 30.77%
Simvastatin: 4 people, 30.77%
Bisoprolol Fumarate And Hydrochlorothiazide: 4 people, 30.77%
Vitamin B12: 3 people, 23.08%
Topamax: 3 people, 23.08%
Synthroid: 3 people, 23.08%
Betaseron: 3 people, 23.08%
Micardis: 2 people, 15.38%
Naratriptan: 2 people, 15.38%

What are other side effects people have besides Gastric ulcer? *

Gastric Haemorrhage (bleeding stomach): 5 people, 38.46%
Anaemia (lack of blood): 4 people, 30.77%
Influenza Like Illness: 4 people, 30.77%
Haemoglobin Decreased: 3 people, 23.08%
White Blood Cell Count Increased: 2 people, 15.38%
Coagulation Time Shortened: 2 people, 15.38%
Le Cells Present: 2 people, 15.38%
Haemorrhage (bleeding): 2 people, 15.38%
Haematochezia (passage of stools containing blood): 2 people, 15.38%
Haematemesis (vomiting of blood): 2 people, 15.38%

What are the existing conditions these people have? *

Headache (pain in head): 3 people, 23.08%
Pain: 2 people, 15.38%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 15.38%
Muscle Aches (muscle pain): 2 people, 15.38%
Migraine (headache): 2 people, 15.38%
Joint Pain: 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Weakness: 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Extavia and have Gastric ulcer?

- Check whether Gastric ulcer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Extavia:

Extavia (4,888 reports)

Gastric ulcer treatments and more:

Gastric ulcer (113,573 reports)

Browse all side effects of Extavia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastric ulcer:

Gastric ulcer (1,954 drugs)

Browse all the conditions that are associated with Gastric ulcer:

Gastric ulcer (3,385 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on interferon beta-1b (the active ingredients of Extavia) and Extavia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.